Commercialisation of Biopharmaceutical Raw Materials: A Global Leap for Korean Companies
Director Jeong Min Choi discusses the advancements and strategies behind Korean companies' push to commercialise biopharmaceutical raw materials on a global scale, highlighting innovation, collaboration, and future growth opportunities in this rapidly evolving industry.
Korea Biomedicine Industry Association (KoBIA)
-
Country/Region:Korea, Republic Of
-
On CPHI since:2022